A modified staging classification for cutaneous T-cell lymphoma

Journal of the American Academy of Dermatology
M Kashani-SabetHerschel S Zackheim

Abstract

Despite refinements in the diagnosis of cutaneous T-cell lymphoma (CTCL), since 1979 there have been no changes to the staging of CTCL used to classify mycosis fungoides and Sézary syndrome. We reviewed the current staging of CTCL and examined the usefulness of a new staging scheme for mycosis fungoides and Sézary syndrome. We determined overall survival of 450 patients with mycosis fungoides and Sézary syndrome using the current and modified staging classifications. There were no significant differences between survival of patients with stage IB (patches/plaques involving greater than 10% body surface area) and IIA (peripheral adenopathy) disease and of patients with stage IIB (tumor) and III (erythroderma) disease. There was a significant difference in survival between patients with extensive patch versus extensive plaque stage disease. Modification of the current classification by splitting T2 into patch versus plaque stage disease and incorporating tumors and erythroderma into stage III proved superior to the current scheme in predicting overall survival. Modification of the current staging classification for CTCL yields subgroups useful in the prognostic assessment of CTCL.

Citations

Jul 14, 2010·Journal of Biomedicine & Biotechnology·Anna VaskuVladimir Vasku
Jan 31, 2012·Journal of the American Academy of Dermatology·H Miles PrinceDavid J Straus
Apr 6, 2005·International Journal of Dermatology·Lap-shing Ku, Kuen-kong Lo
Dec 16, 2003·Skinmed·Jennifer H DoAnthony A Gaspari
Jul 5, 2006·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Mitsuru MiyoshiKenmei Takaichi
May 11, 2006·Journal of the European Academy of Dermatology and Venereology : JEADV·F PavlotskyH Trau
Sep 14, 2012·Photodermatology, Photoimmunology & Photomedicine·Robert KnoblerLarisa Geskin
Mar 20, 2014·The British Journal of Dermatology·J J ScarisbrickP Quaglino
Jul 29, 2004·Journal of the American Academy of Dermatology·Apostolia-Maria TsimberidouRazelle Kurzrock
May 20, 2005·Clinical Oncology : a Journal of the Royal College of Radiologists·V McFarlaneT M Illidge
May 20, 2014·Journal of the American Academy of Dermatology·Felix PavlotskyAviv Barzilai
Aug 25, 2016·The British Journal of Dermatology·V NikolaouC Antoniou
Apr 4, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Franz TrautingerRobert Knobler
Apr 4, 2019·Medicinal Research Reviews·Nathalia Rodrigues de Almeida, Martin Conda-Sheridan
Jun 19, 2012·American Journal of Clinical Oncology·Ginette A HindsLynn D Wilson
Nov 26, 2002·Hematology·Joseph M ConnorsFrancine M Foss
Dec 8, 2005·Proceedings·Jennifer Clay CatherM Alan Menter
Nov 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroki YanoRyuzo Ueda
Jul 17, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Leigh EllisH Miles Prince
May 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Yasuyuki FujitaHiroshi Shimizu
Aug 30, 2019·The Journal of Investigative Dermatology·Ahmed Mourad, Robert Gniadecki
Mar 4, 2021·JAMA Dermatology·Joon Min JungWoo Jin Lee

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Journal of the American Academy of Dermatology
Elisabeth Fraser-AndrewsR Russell-Jones
Journal of Cutaneous Pathology
Emmilia Hodak, Michael David
© 2021 Meta ULC. All rights reserved